Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

BACKGROUND: Myanmar has set national hepatitis C (HCV) targets to achieve 50% of people diagnosed and 50% treated by 2030. The WHO has additional targets of reducing incidence by 80% and mortality by 65% by 2030. We aimed to estimate the impact, cost, cost-effectiveness and net economic benefit of a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet Reg Health West Pac
Autors principals: Scott, Nick, Win, Thin Mar, Tidhar, Tom, Htay, Hla, Draper, Bridget, Aung, Phyo Thu Zar, Xiao, Yinzong, Bowring, Anna, Kuschel, Christian, Shilton, Sonjelle, Kyi, Khin Pyone, Naing, Win, Aung, Khin Sanda, Hellard, Margaret
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8315611/
https://ncbi.nlm.nih.gov/pubmed/34327345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lanwpc.2021.100129
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars